Oxygen Consumption and Sevoflurane Uptake Based on Physiological Dead Space Estimation
Launched by FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SEVILLA · Aug 22, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how well the amount of oxygen and a specific anesthetic called sevoflurane are used in patients undergoing robotic prostate surgery. The researchers want to see if their method for calculating how much of these gases is needed, based on certain measurements, matches what is actually used by the body during surgery. All participants will be supported with a special ventilation technique to help keep their lungs open during the procedure.
To participate in this study, you need to be an adult (18 years or older) who is scheduled for robotic prostate surgery at the research site and can provide written consent. However, if you have certain health conditions, such as severe heart or lung issues, or if you have participated in another study recently, you may not be eligible. If you qualify and choose to join, you can expect to receive close monitoring during your surgery to ensure your safety and comfort.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult subjects (≥ 18 years) scheduled for robotic prostatic surgery at the investigators´ institution
- • Written informed consent
- Exclusion Criteria:
- • Participation in another interventional study
- • Participants unable to understand the information contained in the informed consent
- • American Society of Anesthesiologists (ASA) classification grade = IV
- • Patient in dialysis
- • Chronic obstructive pulmonary disease (COPD) grade Global Initiative for Chronic Obstructive Lung Disease(GOLD) \> 2
- • Functional vital capacity \< 60% or \> 120% of the predicted
- • Body mass index (BMI) \> 35 kg/m2
- • Relation arterial pressure of oxygen (PaO2)/FiO2 \<200 mmHg in the baseline sample
- • Presence of mechanical ventilation in the 72 hours prior to enrollment
- • New York Heart Association (NYHA) functional class ≥ 3
- • Clinically suspected heart failure
- • Diagnosis or suspicion of intracranial hypertension
- • Presence of pneumothorax or giant bullae on preoperative imaging tests
- • Use of Continuous Positive Airway Pressure (CPAP).
About Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla
The Fundación Pública Andaluza para la Gestión de la Investigación en Sevilla is a public foundation dedicated to advancing clinical research and innovation within the Andalusian healthcare system. By fostering collaboration among healthcare professionals, researchers, and institutions, the foundation aims to enhance the quality and efficiency of clinical trials. With a strong focus on ethical standards and regulatory compliance, it plays a pivotal role in supporting the development of new therapies and improving patient outcomes in the region. Through its commitment to scientific excellence and community health, the foundation contributes significantly to the advancement of medical knowledge and practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seville, , Spain
Patients applied
Trial Officials
Manuel de la Matta, MD
Principal Investigator
Hospitales Universitarios Virgen del Rocío
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials